Tuesday, March 23, 2021

Design Therapeutics Sets IPO Offering Range

Carlsbad-based Design Therapeutics, a company developing treatments for serious degenerative disorders, has set an expected IPO offering range of between $18.00 and $20.00 per share, the company said in a filing this week. The company has applied to list on the Nasdaq Global Market as DSGN. The company is venture backed by SR One, Quan Capital, Cormora

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.